Clinical Trial
doi: 10.1177/030006057600400608.
A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis
- PMID: 800382
- DOI: 10.1177/030006057600400608
Item in Clipboard
Clinical Trial
A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis
J Int Med Res.
1976.
Abstract
Twenty-three patients with rheumatoid arthritis participated in a double-blind crossover investigation of ketoprofen (Orudis) and indomethacin. Ratings which assessed the degree of joint involvement showed consistently greater improvement with Orudis, and side-effects occurred with less frequency. The majority of patients expressed a definite preference for Orudis.
Similar articles
-
Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin.Rheumatol Rehabil. 1976;Suppl:50-1. doi: 10.1093/rheumatology/15.5.50. Rheumatol Rehabil. 1976. PMID: 796942 Clinical Trial.
-
Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin.Scand J Rheumatol Suppl. 1976;1976(0):93-8. Scand J Rheumatol Suppl. 1976. PMID: 790554 Clinical Trial.
-
Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind cross-over trial.Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):205-8. doi: 10.1007/BF00567116. Eur J Clin Pharmacol. 1975. PMID: 786679 Clinical Trial. No abstract available.
-
Ketoprofen: a review of its pharmacologic and clinical properties.Pharmacotherapy. 1986 May-Jun;6(3):93-103. doi: 10.1002/j.1875-9114.1986.tb03459.x. Pharmacotherapy. 1986. PMID: 3526298 Review.
-
Patients' preference in indomethacin trials: an overview.Lancet. 1989 Jan 14;1(8629):88-91. doi: 10.1016/s0140-6736(89)91439-6. Lancet. 1989. PMID: 2562891 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
